William Nyberg
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Articles (9)
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Melanoma tumors are highly metastatic partly due to the ability of melanoma cells to transition between invasive and proliferative states. However, the mechanisms underlying this plasticity are still not fully understood. To identify new epigenetic regulators of melanoma plasticity, we combined data mining, tumor models, proximity proteomics, and CUT&RUN sequencing. We focus on the druggable family of bromodomain epigenetic readers and identify TRIM28 as a new regulator of melanoma plasticity. We find that TRIM28 promotes the expression of pro‐invasive genes and that TRIM28 controls the balance between invasiveness and growth of melanoma cells. We demonstrate that TRIM28 acts via the transcription factor JUNB that directly regulates the expression of pro‐invasive and pro‐growth genes. Mechanistically, TRIM28 controls the expression of JUNB by negatively regulating its transcriptional elongation by RNA polymerase II. In conclusion, our results demonstrate that a TRIM28–JUNB axis controls the balance between invasiveness and growth in melanoma tumors and suggest that the bromodomain protein TRIM28 could be targeted to reduce tumor spread.
Year:
2022
Year:
2020
Collaborators (9)
Theodore Roth
Chief Scientific Officer, Co-Founder
-
Gudny Ella Thorlacius
Karolinska Institutet
Sagar Bapat
University of California, San Francisco
Eric Herlenius
Karolinska University Hospital
Dalia Haydar
Assistant Professor
-
Justin Eyquem
Assistant Professor
University of California, San Francisco
Scott C. Kogan
University of California, San Francisco
Alexander Espinosa
-
Ralf Schmidt
Medical University of Vienna
Make your next move.
Prepare your application
Review drafts before you send them.